(Reuters Health) - A class of medications used for nerve and muscle pain, including the popular drug Lyrica, increases users' risks for suicidal behavior, unintentional overdoses, injuries and car accidents - and the risks are particularly high for teens and young adults, new research shows.
(Reuters Health) - Preventing falls among elderly patients who've just left the hospital is an important part of keeping them safe, a large U.S. study shows.
(Reuters Health) - Researchers have harnessed the power of social media to build a genetic database, according to a new report.
(Reuters Health) - Researchers have harnessed the power of social media to build a genetic database, according to a new report.
VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an older vaccine from GlaxoSmithKline, sending its shares plunging 66%.
VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an older vaccine from GlaxoSmithKline, sending its shares plunging 66%.
For several decades, certain cancer centers have been allowed by the U.S. government to charge more for the care they give. A new study finds the care given at these centers isn't very different from that received at other top-notch facilities.
Zebra Medical Vision, an Israel medical imaging analytics company, said on Monday it received its third clearance from the U.S. Food and Drug Administration for its alert for intracranial hemorrhage, based on head CT scans.
Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain's largest drugmaker told Reuters.
The United States recorded 22 new measles cases last week, bringing the year's total number of cases to 1,044 in the worst outbreak of the disease since 1992, federal health officials said on Monday.